Oxaceprol
Names
[ CAS No. ]:
33996-33-7
[ Name ]:
Oxaceprol
[Synonym ]:
AHP-200
trans-1-Acetyl-4-hydroxy-1-proline
Jonctum
(2S,4R)-1-acetyl-4-hydroxypyrrolidine-2-carboxylic acid
N-Acetyl-L-hydroxyproline
Oxaceprol
L-Proline, 1-acetyl-4-hydroxy-, (4R)-
(2S,4R)-N-acetyl-4-hydroxyproline
CO-61
trans-l-prolin
(4R)-1-Acetyl-4-hydroxy-L-proline
(2S,4R)-1-acetyl-4-hydroxy-2-pyrrolidinecarboxylic acid
MFCD00037339
(-)-1-Acetyl-4-hydroxy-L-proline
AC-HYDROXYPROLINE
Hyp4001Ac-Hyp-Oh
N-acetyl-trans-4-hydroxy-L-proline
EINECS 251-780-6
(2S,4R)-1-acetyl-4-hydroxy-proline
1-acetyl-trans-4-hydroxy-L-proline
N-AC-L-HYP
Ac-L-Hyp-OH
AC-HYP-OH
N-Acetyl-L-4-Hydroxyproline
Biological Activity
[Description]:
[Related Catalog]:
[References]
[Related Small Molecules]
Chemical & Physical Properties
[ Density]:
1.4±0.1 g/cm3
[ Boiling Point ]:
442.1±45.0 °C at 760 mmHg
[ Melting Point ]:
132-133 °C (dec.)(lit.)
[ Molecular Formula ]:
C7H11NO4
[ Molecular Weight ]:
173.167
[ Flash Point ]:
221.2±28.7 °C
[ Exact Mass ]:
173.068802
[ PSA ]:
77.84000
[ LogP ]:
-2.04
[ Vapour Pressure ]:
0.0±2.4 mmHg at 25°C
[ Index of Refraction ]:
1.561
MSDS
Safety Information
[ Symbol ]:
GHS05
[ Signal Word ]:
Danger
[ Hazard Statements ]:
H318
[ Precautionary Statements ]:
P280-P305 + P351 + P338
[ Personal Protective Equipment ]:
dust mask type N95 (US);Eyeshields;Gloves
[ Hazard Codes ]:
Xi: Irritant;
[ Risk Phrases ]:
R41
[ Safety Phrases ]:
S26-S36
[ RIDADR ]:
NONH for all modes of transport
[ WGK Germany ]:
3
[ HS Code ]:
2933990090
Synthetic Route
Precursor & DownStream
Precursor
DownStream
Customs
[ HS Code ]: 2933990090
[ Summary ]:
2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%
Articles
Acta Orthop. Scand. 72(3) , 293-8, (2001)
Oxaceprol (N-acetyl-L-hydroxyproline), an atypical inhibitor of inflammation, is an established drug forjoint disease without serious side-effects. Recent studies have emphasized that oxaceprol has an...
Determination of oxaceprol in rat plasma by LC-MS/MS and its application in a pharmacokinetic study.J. Pharm. Biomed. Anal. 54(1) , 173-8, (2011)
A sensitive method for the quantification of oxaceprol in rat plasma using high-performance liquid chromatography-tandem mass spectrometry (LC-MS/MS) was developed. Sample pretreatment involved a simp...
[Assessment of the placebo effect of symptomatic slow-acting anti-arthritics].Presse Med. 27(5) , 211-4, (1998)
Assess the importance of the mid-term placebo effect of symptomatic slow acting drugs given for osteoarthritis.We analyzed six controlled trials available in the literature. Trial duration ranged from...